On September 7, 2021 Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to potentially create new treatments that make a meaningful difference in patients’ lives, reported that the company will participate in two upcoming investor conferences (Press release, Ascendis Pharma, SEP 7, 2021, View Source [SID1234587305]). Company executives will provide a business overview and update on the company’s programs.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details

Event 2021 Virtual Wells Fargo Healthcare Conference
Location Virtual
Date Friday, September 10, 2021
Time 2:40 p.m. Eastern Time

Event Morgan Stanley 19th Annual Global Healthcare Conference
Location Virtual
Date Wednesday, September 15, 2021
Time 12:30 p.m. Eastern Time
A live webcast of the presentations will be available in the Investors and News section of the Ascendis Pharma website at www.ascendispharma.com. A webcast replay will also be available on this website shortly after conclusion of the events for 30 days.